8-K/A XBRL

FORM 8-K/A

Company: Theravance Biopharma, Inc.
Filed: March 1, 2023
Period of Report: December 9, 2022
Accession Number: 0001104659-23-027339

View Document ↗ View on SEC.gov ↗